Natick, MA and San Francisco, CA-- Boston Scientific Corporation reports positive outcomes from the CABANA post-approval study of the Carotid WALLSTENT ® Monorail ® Endoprosthesis used in conjunction ...
Boston Scientific has recalled its Carotid Wallstent Monorail endoprosthesis, used to treat narrowed carotid arteries, due to a manufacturing defect that increases the risk of resistance when ...
Ordinarily when a study reveals that one device is as effective as the gold standard the news is considered good – but not fantastic – for the maker of the new device. But that's not at all Cook ...
With the introduction of self-expanding stents, an increased number of complex diseases were treated, with success rates comparable to those of open surgery. [14,15] In a contemporary study, the use ...
Boston Scientific (BSX) is launching a new registry in China called “A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT in Chinese Population.” The ...
The U.S. FDA has announced a class I recall for the Wallstent Monorail system by Boston Scientific Corp. of Marlborough, Mass, a device for treatment of carotid artery stenosis. The company advised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results